Abstract:BackgroundUrinary tract infections (UTI) are one of the most common infectious diseases diagnosed in the community as well as in hospitals. Community-acquired urinary tract infections caused by Escherichia coli represent the largest proportion of infectious diseases affecting women and a significant amount of oral antibiotics are prescribed daily to treat UTI in community outpatient clinics. Having knowledge of regional susceptibility data regarding E. coli is very important for selecting an appropriate empirical antibiotic. This study aimed to report the frequency and antimicrobial susceptibility of E. coli isolated from community-acquired urinary tract infections post-Covid-19 pandemic.MethodsThis study was a retrospective analysis from January to December 2023 based on the analysis of 24,019 uropathogens isolated from 182 outpatient health centers located in several regions of São Paulo city, Brazil. The urine samples were cultivated onto ChromIDTMCPS® agar plates by semi-quantitative technique using 1μL disposable loop, incubated at 35-37°C and the colony counting were read after 24h and 48h of incubation. The bacteria identification was performed by MALDI-TOF mass spectrometry (Vitek-MS), and the minimal inhibitory concentrations of antibiotics were determined using the Vitek ® 2 system, according to the manufacture's recommendations. Only positive results with one bacterial species and a colony count ≥10 5 CFU/mL was considered for descriptive analysis.ResultsOf the 24,019 urine samples tested, 71.44% (17,159/24,019) were identified as Escherichia coli. The major frequency of E. coli infection occurred among women (90.48%) and the main age range was over 60 years (38.57%), while 21-30 comprised 16.5% of cases. The antimicrobial resistance profile for E. coli isolates showed 39.9% (6852/17158) of resistance to ciprofloxacin (MIC, >0.5 mg/L), 34.7% (5,921/17,075) to trimethoprim/sulfamethoxazole (MIC, >0.5 mg/L), 37.5% (6,371/17,002) to Amoxicillin/clavulanate (MIC, >8 mg/L), 8.75% (1,501/17,592) to ceftriaxone (MIC, >1 mg/L), 4.88% (837/17,138) to cefepime (MIC, >4 mg/L), 3.64% (616/16,901) to piperacillin/tazobactam (MIC, >8 mg/L), 11.07% (1,900/17,156) of gentamicin (MIC, >2 mg/L), 0.43% (74/17,158) of amikacin (MIC, >8 mg/L) and 2.23% (377/16,909) of fosfomycin (MIC, >16 mg/L). High-level of susceptibility was detected to carbapenems with 99.94% (10/17159) to ertapenem (MIC, ≤0.5 mg/L) and 99.8% (4/17,159) to meropenem (MIC, ≤2 mg/L). The rate of Extended-spectrum beta-lactamase production was 8.1% (1391/17159).ConclusionsThis data could be used locally with other related samples, to properly interpret significant resistance patterns and choose the most appropriate antimicrobial for empirical treatment of patients with community-acquired urinary tract infections.

High frequency of Enterococcus faecalis detected in urinary tract infections in male outpatients – a retrospective, multicenter analysis, Germany 2015 to 2020

Antimicrobial susceptibilities of aerobic and facultative gram-negative bacilli isolated from Chinese patients with urinary tract infections between 2010 and 2014

A study of uropathogenic Escherichia coli from men in regional NSW (Australia) with special emphasis on antibiotic resistance

The percentage of antibiotic resistance in uncomplicated community-acquired urinary tract infections—findings of the RedAres project

Analysis of Pathogenic Bacteria in Urinary Tract Infection From 2016 to 2017

An Investigation of the Male Genitourinary Abscess Originated from Urinary Tract in a Tertiary Hospital, Shanghai, China, from 2004 to 2019

Epidemiological trends and susceptibility patterns of bloodstream infections caused by Enterococcus spp. in six German university hospitals: a prospectively evaluated multicentre cohort study from 2016 to 2020 of the R-Net study group

Treatment, outcomes and characterization of pathogens in urinary tract infections caused by ESBL-producing Enterobacterales: a prospective multicentre study

Identification of Enterococcus faecalis in a patient with urinary-tract infection based on metagenomic next-generation sequencing: a case report

The rise in vancomycin-resistant Enterococcus faecium in Germany: data from the German Antimicrobial Resistance Surveillance (ARS)

Epidemiological insights into seasonal, sex‐specific and age‐related distribution of bacterial pathogens in urinary tract infections

Prescription of antibiotics for urinary tract infections in outpatient care in Bavaria: An analysis of routine data

Heterogeneity and Metabolic Diversity among Enterococcus Species during Long-term Colonization

Incidence and Recurrence of Urinary Tract Infections Caused by Uropathogenic Escherichia coli: A Retrospective Cohort Study

A-253 Antimicrobial Susceptibility Pattern in Escherichia coli Isolated From Community-Acquired Urinary Tract Infections in the era Post-Covid-19

Uncovering Surface Penetration by Enterococci From Urinary Tract Infection Patients

The EC-COMPASS: Long-term, multi-centre surveillance of Enterobacter cloacae complex - a clinical perspective

Antibiotic resistance patterns of more than 120 000 clinical Escherichia coli isolates in Southeast Austria, 1998–2013

Microbial Etiology and Resistance Patterns of Urinary Tract Infection at a Tertiary Care Centre – A Hospital based Study

Antimicrobial susceptibility pattern and epidemiology of male urinary tract infections in China, 2012

Epidemiological and genetic characteristics of vancomycin-resistant Enterococcus faecium isolates in a University Children's Hospital in Germany: 2019 to 2020